Mantle cell lymphoma with aberrant expression of CD10

Histopathology

Volumn 53, Issue 1, 2008, Pages 20-29

  Zanetto, U ^a   Dong, H ^b   Huang, Y ^c   Zhang, K ^d   Narbaitz, M ^e   Sapia, S ^f   Kostopoulos, I ^g   Liu, H ^c   Du, M Q ^c   Bacon, C M ^c  

^a CITY HOSPITAL   (United Kingdom)

^b Genzyme Genetics   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GEISINGER MEDICAL CENTER   (United States)

^e INST DE INVEST HEMATOLOGICAS   (Argentina)

^f Fundaleu ^*  (Argentina)

^g ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Bcl 6; CD10; Genetics; Immunohistochemistry; Mantle cell lymphoma

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 6;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BLAST CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; CELL STRUCTURE; CELL TRANSFORMATION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; DIAGNOSTIC VALUE; DISEASE COURSE; DISSEMINATED CANCER; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; MALE; MANTLE CELL LYMPHOMA; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SOMATIC MUTATION;

AGED; B-LYMPHOCYTES; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLINS; DNA-BINDING PROTEINS; FEMALE; GERMINAL CENTER; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEPRILYSIN; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

BLASTOIDEA;

EID: 45549104924     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03060.x     Document Type: Article

References (37)

1. Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum. Pathol. 2002 33 7 20.
2. Swerdlow SH, Berger F, Isaacson PG et al. Mantle cell lymphoma. In Jaffe ES, Harris NL, Stein H, Vardiman JW eds. World Health Organisation classification of tumour. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon:IARC Press, 2001 168 170.
3. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997 89 2067 2078.
4. Zucca E, Stein H, Coiffier B. European lymphoma task force (ELTF): report of the workshop on mantle cell lymphoma (MCL). Ann. Oncol. 1994 5 507 511.
5. Camacho FI, Algara P, Rodriguez A et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood 2003 101 4042 4046.
6. Walsh SH, Thorselius M, Johnson A et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 2003 101 4047 4054.
7. Kienle D, Krober A, Katzenberger T et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003 102 3003 3009.
8. Orchard J, Garand R, Davis Z et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 2003 101 4975 4981.
9. Rosenberg CL, Wong E, Petty EM et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. U.S.A. 1991 88 9638 9642.
10. Rosenwald A, Wright G, Wiestner A et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003 3 185 197.
11. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am. J. Clin. Pathol. 1995 103 756 760.
12. Swerdlow SH, Zukerberg LR, Yang WI, Harris NL, Williams ME. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Am. J. Surg. Pathol. 1996 20 627 640.
13. Bosch F, Jares P, Campo E et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994 84 2726 2732.
14. Bea S, Ribas M, Hernandez JM et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999 93 4365 4374.
15. Ott G, Kalla J, Hanke A et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leuk. Lymphoma 1998 32 55 63.
16. Zoldan MC, Inghirami G, Masuda Y et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br. J. Haematol. 1996 93 475 486.
17. Liu Z, Dong HY, Gorczyca W et al. CD5- mantle cell lymphoma. Am. J. Clin. Pathol. 2002 118 216 224.
18. Kaptain S, Zukerberg LR, Ferry JA, Harris NL. BCL-1 cyclin D1+ CD5- mantle cell lymphoma. Mod. Pathol. 1998 11 133A.
19. Camacho FI, Garcia JF, Cigudosa JC et al. Aberrant Bcl6 protein expression in mantle cell lymphoma. Am. J. Surg. Pathol. 2004 28 1051 1056.
20. Morice WG, Hodnefield JM, Kurtin PJ, Hanson CA. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10. Am. J. Clin. Pathol. 2004 122 122 127.
21. Dong HY, Gorczyca W, Liu Z et al. B-cell lymphomas with coexpression of CD5 and CD10. Am. J. Clin. Pathol. 2003 119 218 230.
22. Xu Y, McKenna RW, Kroft SH. Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. Am. J. Clin. Pathol. 2002 117 291 300.
23. van Dongen JJ, Langerak AW, Bruggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003 17 2257 2317.
24. Foran JM, Norton AJ, Micallef IN et al. Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis. Br. J. Haematol. 2001 114 881 883.
25. Kostopoulos I, Cocco M, Ginanneschi C et al. Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases. Virchows Arch. 2006 449 320 327.
26. Weisenburger DD, Vose JM, Greiner TC et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am. J. Hematol. 2000 64 190 196.
27. Bernard M, Gressin R, Lefrere F et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia 2001 15 1785 1791.
28. Tiemann M, Schrader C, Klapper W et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br. J. Haematol. 2005 131 29 38.
29. Yin CC, Medeiros LJ, Cromwell CC et al. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod. Pathol. 2007 20 1 7.
30. Salaverria I, Zettl A, Bea S et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J. Clin. Oncol. 2007 25 1216 1222.
31. Iqbal J, Greiner TC, Patel K et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007 21 2332 2343.
32. Saito M, Gao J, Basso K et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 2007 12 280 292.
33. Lai R, Lefresne SV, Franko B et al. Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated genotype correlates with better clinical outcome. Mod. Pathol. 2006 19 1498 1505.
34. Muller-Hermelink HK, Greiner A. Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. Am. J. Pathol. 1998 153 1341 1346.
35. Pittaluga S, Tierens A, Pinyol M et al. Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. Br. J. Haematol. 1998 102 1301 1306.
36. Cogliatti SB, Bertoni F, Zimmermann DR et al. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome. J. Pathol. 2005 206 320 327.
37. Chu PG, Chang KL, Weiss LM, Arber DA. Immunohistochemical detection of CD10 in paraffin sections of hematopoietic neoplasms: a comparison with flow cytometry detection in 56 cases. Appl. Immunohistochem. Mol. Morphol. 2000 8 257 262.